Name
G protein-coupled receptor 35
MGI ID
MGI:1929509
Synonyms
N/A
Viability
View
N/A
Significant phenotypes (0)
All measurements (551)
Expression & images (0)
Disease models (0)
Order (4)
View data by physiological system
Significant
Not Significant
Not tested
No results meet the p-value threshold
Filtered by: all phenotypes
Mouseover the data points for more information. Click and drag to zoom the chart. Click on the legends to disable/enable data.
| Allele | Center | Procedure / Parameter | Zygosity | Mutants | Statistical Method |
P Value | Status | |
|---|---|---|---|---|---|---|---|---|
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total T cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forepaw footpad size | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector gd cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Bulging eye | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / External genitalia morphology | HOM | 7f:7m | Fisher Exact Test framework | 0.0159 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total CD4+ NKT cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / B cell number | HOM | 5f:5m | 0.229 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / B cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / NKT cell number | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / NKT cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Pre-pro B cells (Hardy fraction A) - % of B220+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ Treg cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Iris/Pupil | HOM | 6f:7m | Fisher Exact Test framework | 0.156 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Snout morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Hematology / Mean cell hemoglobin concentration | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.612 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Kyphosis | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Lumbar processes | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Incisors morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total B cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Fibula | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Auditory Brain Stem Response / 6kHz-evoked ABR Threshold | HOM | 0f:4m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Shape of vertebrae | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Trunk curl | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Naive CD8+ T cells - % of CD8+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector gd T cells - % of gd T cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Body Composition (DEXA lean/fat) / Body length | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0206 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ gd T cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Plasmacytoid DC - % of DC | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Lens Opacity | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Ly6C+ mature NK cells - % of mature NK cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Limb skin appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / LDL-cholesterol | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.258 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Conventional DC (cDC) - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Follicular B cells - % of B2 cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindlimb size | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forepaw morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector CD4+ T helper cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Follicular B cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ Treg cells - % of Treg | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Zygomatic bone | HOM | 7f:7m | Fisher Exact Test framework | 0.0238 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Head skin colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Head coat/hair length | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Calcium | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.619 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Ventral coat/hair colour pattern | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Shape of ribs | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Limb coat/hair length | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / CD4+ T helper cells - % of CD4+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Macrophages - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / CD4+ T helper cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Tail length | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Potassium | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.583 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total CD4- NKT cells - % of NKT cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Myeloid cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Auditory Brain Stem Response / 30kHz-evoked ABR Threshold | HOM | 0f:4m | 0.112 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total CD8+ T cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Phosphorus | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.0505 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Germinal centre B cells - % of B2 cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Viability Primary Screen / Outcome | HOM | 37f:34m | Supplied as data | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Plasmacytoid DC - % of DC | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Head bobbing/circling | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forepaw nail colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Digit coat/hair colour pattern | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / B1a cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting CD8+ T cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Corneal vascularization | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Retinal Blood Vessels Pattern | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Triglycerides | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.0778 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Head size | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Hematology / Platelet count | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.158 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / External genitalia | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting gd T cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting CD4+ T helper cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindlimb morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Follicular B cells - % of B2 cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Transfer arousal | HOM | 7f:7m | Fisher Exact Test framework | 0.0236 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell number | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell number | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Pupil Position | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Limb skin colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Ear epidermis immunophenotyping / Average volume of LC | HOM | 3f:3m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Ear epidermis immunophenotyping / Average volume of LC | HOM | 1f:1m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Scoliosis | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Incisor colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Plasmacytoid DC - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Early germinal centre B cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Fusion of vertebrae | HOM | 7f:7m | Fisher Exact Test framework | 0.618 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Tibia | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Conventional DC (cDC) - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / CD5+ gd T cells - % of gd T cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Head skin appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting Treg cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Paw footpad skin appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting CD4+ NKT cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total CD4+ T cells - % of ab T cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Digit coat/hair appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Lens | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting gd T cells - % of gd T cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector CD4+ T helper cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / CD11b-high cDC - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Tail morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Sodium | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.684 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Ventral coat/hair colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total B cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Germinal centre B cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Body Composition (DEXA lean/fat) / Bone Mineral Content (excluding skull) | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.00202 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Ly6C+ NKT cells - % of NKT cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Corneal touch reflex | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / CD11b-low cDC - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Contact righting reflex | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forepaw nail morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / HDL-cholesterol | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.0567 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector CD8+ T cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Persistence of hyaloid vascular system | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector NK cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Granulocytes - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Maxilla/Pre-maxilla | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Mature NK cells - % of NK cellls | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector CD4- NKT cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Gait (inc. ataxia) | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Tail coat/hair appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Naive CD8+ T cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting NK cells - % of NK cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Caudal processes | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Ventral skin appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindlimb | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total B2 cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Head morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Dorsal coat/hair colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Number of ribs right | HOM | 7f:7m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting CD4+ NKT cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total DC - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Alpha-amylase | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.285 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ gd T cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Iron | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.665 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting Treg cells - % of Treg | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Magnesium | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.115 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Transitional 1 B cells - % of B2 cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Convulsions | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Plasmacytoid DC - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forepaw digit size | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Monocyte number | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Monocyte number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / CD103+ CD11b-low cDC - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector Treg cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Ear epidermis immunophenotyping / Average branch length of LC | HOM | 1f:1m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Ear epidermis immunophenotyping / Average branch length of LC | HOM | 3f:3m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindpaw digit fusion | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector NK cells - % of NK cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Tail | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting Treg cells - % of Treg | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Ventral coat/hair appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | DSS Histology / Pre-Day 10 Death | HOM | 3f:0m | - | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Limb coat/hair appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Femur | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil number | HOM | 5f:5m | 0.0270 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Pinna | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Free fatty acids | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.126 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Cornea | HOM | 6f:7m | Fisher Exact Test framework | 0.245 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting CD4+ T helper cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Germinal centre B cells - % of B2 cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Auditory Brain Stem Response / 12kHz-evoked ABR Threshold | HOM | 0f:4m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil percentage | HOM | 5f:5m | 0.0284 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting CD8+ T cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Immature B cells (Hardy fraction E) - % of B220+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Body Composition (DEXA lean/fat) / Bone Mineral Density (excluding skull) | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0489 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Follicular B cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Pinna position | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Hematology / Red blood cell count | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.103 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Paw coat/hair colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindpaw digit count | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting gd T cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Iris Pigmentation | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Mature NK cells - % of lymphocytes | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Paw footpad skin colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / CD11b-high cDC - % of cDC | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Granulocytes - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Startle response | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Thoracic processes | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Humerus | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector CD8+ T cells - % of CD8+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / NK cell number | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / NK cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Total B cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN) | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.0341 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / CD5+ gd T cells - % of gd T cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Number of lumbar vertebrae | HOM | 7f:7m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Lordosis | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Eosinophils - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Ventral skin colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector CD4+ NKT cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Ulna | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Memory B cells - % of B2 cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Sacral processes | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Tail coat/hair length | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector Treg cells - % of Treg | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD8+ T cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total DC - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forepaw digit count | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Digit coat/hair presence | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / External genitalia size | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Number of caudal vertebrae | HOM | 7f:7m | 0.0114 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ NK cells - % of NK cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / NK cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / NK cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Number of ribs left | HOM | 7f:7m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Memory B cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindpaw nail colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Ventral coat/hair length | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Body Composition (DEXA lean/fat) / Bone Area | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.000628 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total NK cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total CD4+ T cells - % of ab T cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Transitional 2 B cells - % of B2 cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell number | HOM | 5f:5m | 0.229 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Ear epidermis immunophenotyping / Average roundness of LC | HOM | 3f:3m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Ear epidermis immunophenotyping / Average roundness of LC | HOM | 1f:1m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total CD4- NKT cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindpaw digit morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Mature B cells (Hardy fraction F) - % of B220+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Tail skin colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Dorsal coat/hair presence | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Paw coat/hair presence | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Pinna morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindpaw digit size | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Transitional 2 B cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Mature B cells (Hardy fraction F) - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Glucose | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.149 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector CD8+ T cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Fertility of Homozygous Knock-out Mice / Gross Findings Female | HOM | f:m | Supplied as data | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Pre-pro B cells (Hardy fraction A) - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Skull shape | HOM | 7f:7m | Fisher Exact Test framework | 0.289 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total CD8+ T cells - % of ab T cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forelimb | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Ear epidermis immunophenotyping / Langerhans cell (LC) count | HOM | 3f:3m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Ear epidermis immunophenotyping / Langerhans cell (LC) count | HOM | 1f:1m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Digit coat/hair colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Chloride | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.283 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Ly6C+ mature NK cells - % of lymphocytes | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell number | HOM | 5f:5m | 0.247 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Body Composition (DEXA lean/fat) / Lean mass | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0863 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Pupil Light Response | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Corneal opacity | HOM | 6f:7m | Fisher Exact Test framework | 0.0449 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / CD11b-low cDC - % of cDC | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Number of pelvic vertebrae | HOM | 7f:7m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Monocytes - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Shape of ribcage | HOM | 7f:7m | Fisher Exact Test framework | 0.242 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Tremor | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Hematology / White blood cell count | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.158 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total CD4+ NKT cells - % of NKT cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Marginal zone B cells - % of B2 cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Alanine aminotransferase | HOM | 6f:6m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.0958 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Eosinophils - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ NK cells - % of NK cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Naive CD8+ T cells - % of CD8+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Plasma cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Creatinine | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.121 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Dorsal coat/hair appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Number of thoracic vertebrae | HOM | 7f:7m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Marginal zone precursor B cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Limb coat/hair colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / B1a cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Radius | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Memory B cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Tail coat/hair colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Hematology / Mean platelet volume | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.817 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / NKT cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / NKT cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Brachydactyly | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting gd T cells - % of gd T cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total gd T cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Tail skin appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Scapulae | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total CD4- NKT cells - % of NKT cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindpaw nail morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell number | HOM | 5f:5m | 0.0263 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Head coat/hair presence | HOM | 7f:7m | Fisher Exact Test framework | 0.388 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / CD4+ T helper cells - % of CD4+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Naive CD8+ T cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forepaw digit fusion | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Plasma cells - % of B2 cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Immature NK cells - % of lymphocytes | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Retina (combined) | HOM | 6f:7m | Not processed | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting Treg cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Polysyndactylism | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Pinna size | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Hematology / Hematocrit | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.0514 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Memory B cells - % of B2 cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Immature B cells (Hardy fraction E) - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Vibrissae shape | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Creatine kinase | HOM | 5f:6m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.997 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte number | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell number | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total Treg cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Pupil Dilation | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Body Composition (DEXA lean/fat) / Fat mass | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.332 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Pro-B cells (Hardy fraction C) - % of B220+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell number | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Paw coat/hair appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Thyroxine | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.133 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ Treg cells - % of Treg | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total Treg cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Transitional 1 B cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forelimb size | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Tail elevation | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Dorsal skin colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector NK cells - % of NK cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Auditory Brain Stem Response / 18kHz-evoked ABR Threshold | HOM | 0f:4m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindpaw morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total CD4- NKT cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / B cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / B cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Clavicle | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Marginal zone B cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total Treg cells - % of CD4+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Tail coat/hair colour pattern | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Late germinal centre B cells - % of GC cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Digit integrity | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting CD4- NKT cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Marginal zone precursor B cells - % of B2 cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total CD4+ NKT cells - % of NKT cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindpaw nail length | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Total protein | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.679 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Body Composition (DEXA lean/fat) / Fat/Body weight | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.229 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Dorsal coat/hair colour pattern | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector gd T cells - % of gd T cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Number of cervical vertebrae | HOM | 7f:7m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total B2 cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Eyelid closure | HOM | 7f:7m | Fisher Exact Test framework | 0.0168 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Head coat/hair colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ CD8+ T cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte number | HOM | 5f:5m | 0.232 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Limb coat/hair colour pattern | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Pre-B cells (Hardy fraction D) - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Aspartate aminotransferase | HOM | 6f:6m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.990 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector Treg cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Late germinal centre B cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forepaw digit morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting NK cells - % of NK cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / CD5+ gd T cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Hematology / Hemoglobin | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.0114 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Ly6C+ immature NK cells - % of lymphocytes | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Total T cell number | HOM | 5f:5m | 0.0263 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Total T cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Syndactylism | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Plasma cells - % of B2 cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Ly6C+ NKT cells - % of lymphocytes | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total ab T cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector gd cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forelimb morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / CD103+ CD11b-low cDC - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Optic Disc | HOM | 6f:7m | Fisher Exact Test framework | 0.00882 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Narrow eye opening | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / CD11b-low cDC - % of cDC | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Glycerol | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.00260 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Heart Weight / Heart weight | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.00861 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Pre-B cells (Hardy fraction D) - % of B220+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Vibrissae size | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Dorsal skin appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Vibrissae colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell number | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindpaw footpad size | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Pupil Shape | HOM | 6f:7m | Fisher Exact Test framework | 0.0810 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Fertility of Homozygous Knock-out Mice / Gross Findings Male | HOM | f:m | Supplied as data | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Cervical processes | HOM | 7f:7m | Fisher Exact Test framework | 0.369 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector NK cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total CD8+ T cells - % of ab T cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total NK cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Monocytes - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting CD8+ T cells - % of CD8+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Paw coat/hair colour pattern | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindpaw nail count | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Body Composition (DEXA lean/fat) / Lean/Body weight | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0586 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell number | HOM | 5f:5m | 0.229 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Plasma cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Auditory Brain Stem Response / Click-evoked ABR threshold | HOM | 0f:4m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Synechia | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting NK cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Auditory Brain Stem Response / 24kHz-evoked ABR Threshold | HOM | 0f:4m | 0.140 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Total cholesterol | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.115 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Monocyte percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Monocyte percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindpaw | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Albumin | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.255 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Transitional vertebrae | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Pelvis | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Early germinal centre B cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Late germinal centre B cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Pinna rotation | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total ab T cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Shape of spine | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Eyelid morphology | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Hematology / Mean cell volume | HOM | 7f:7m | Not processed | 1.00 | FAILED - Insufficient variability in dependent variable 'IMPC_HEM_005_001' for MM/TF framework. Fisher Exact Test can be better way to do the analysis. | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Pro-B cells (Hardy fraction C) - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / CD11b-low cDC - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector CD8+ T cells - % of CD8+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / CD11b-high cDC - % of cDC | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total NKT cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Pinna skin colour | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ gd T cells - % of gd T cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Positional passivity | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Head coat/hair colour pattern | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forepaw nail length | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forepaw | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Digit coat/hair length | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Macrophages - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total CD4+ T cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Retinal Blood Vessels | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting CD4- NKT cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Early germinal centre B cells - % of GC cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total gd T cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total CD8+ T cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Mandibles | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Vibrissae | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Ventral coat/hair presence | HOM | 7f:7m | Fisher Exact Test framework | 0.0139 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Pinna touch reflex | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Ly6C+ immature NK cells - % of immature NK cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector Treg cells - % of Treg | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Mouth morphology | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Granulocytes - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Effector CD4+ NKT cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Number of digits | HOM | 7f:7m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Trichuris / Presence of worms in caecum | HOM | 6f:0m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Total T cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Total T cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Resting NK cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte percentage | HOM | 5f:5m | 0.232 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Limb coat/hair presence | HOM | 7f:7m | Fisher Exact Test framework | 0.344 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | DSS Histology / Average histology score | HOM | 3f:0m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Incisors | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ NK cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Hindpaw size | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Pro-B cells (Hardy fraction B) - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Plasma cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Fructosamine | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.600 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Alkaline phosphatase | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.785 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Trichuris / Pre day 32 death | HOM | 6f:0m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Eye Hemorrhage or Blood Presence | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Teeth | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Paw coat/hair length | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Immature NK cells - % of NK cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell number | HOM | 5f:5m | 0.0263 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / CD4+ T helper cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total NKT cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Fusion between cornea and lens | HOM | 6f:7m | Fisher Exact Test framework | 0.0246 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Ear epidermis immunophenotyping / DETC coverage | HOM | 3f:3m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Ear epidermis immunophenotyping / DETC coverage | HOM | 1f:1m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Hematology / Mean corpuscular hemoglobin | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.610 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total CD4+ T cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Tail coat/hair presence | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forepaw size | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ NK cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Clinical Chemistry / Total bilirubin | HOM | 6f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.645 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Fusion of ribs | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Conventional DC (cDC) - % of DC | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Limb grasping | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / T cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Body Composition (DEXA lean/fat) / BMC/Body weight | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.00473 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / KLRG1+ gd T cells - % of gd T cells | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Head coat/hair appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Forepaw nail count | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil number | HOM | 5f:5m | 0.229 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Eye Morphology / Retinal Blood Vessels Structure | HOM | 6f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Germinal centre B cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / CD11b-high cDC - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell number | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell number | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Joints | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Resting CD8+ T cells - % of CD8+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / KLRG1+ Treg cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Pinna skin appearance | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | X-ray / Fusion of processes | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Hematology / Red blood cell distribution width | HOM | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withWeight | 0.852 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Snout size | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total CD4+ NKT cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell percentage | HOM | 5f:5m | 1.00 | Success | ||
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell percentage | HOM | 2f:2m | Not processed | 1.00 | FAILED - Not enough mutant or control data | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Ear epidermis immunophenotyping / Average no of branches on LC | HOM | 3f:3m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Ear epidermis immunophenotyping / Average no of branches on LC | HOM | 1f:1m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / CD5+ gd T cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Effector CD4- NKT cells - % of CD45+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Bone marrow immunophenotyping / Pro-B cells (Hardy fraction B) - % of B220+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Mesenteric Lymph Node Immunophenotyping / Total T cells - % of CD45+ | HOM | 5f:5m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Spleen Immunophenotyping / Total Treg cells - % of CD4+ | HOM | 6f:6m | Manual | 1.00 | Success | |
| Gpr35tm1b(EUCOMM)Hmgu | WTSI | Combined SHIRPA and Dysmorphology / Dorsal coat/hair length | HOM | 7f:7m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK |
